Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Arrakis Therapeutics
company
About
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
- 101 - 250
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $38M
- Industries
- Biopharma,Biotechnology,Medical,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Arrakis Therapeutics is a developer of a drug discovery platform intended to target RNA. The company's platform integrates leading-edge RNA bioinformatic and structural tools to produce a pipeline of rSMs to treat a range of disease including neurology, oncology and rare genetic diseases, enabling physicians to offer enhanced care.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$38M
Arrakis Therapeutics has raised a total of
$38M
in funding over 2 rounds. Their latest funding was raised on
Feb 27, 2017 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 27, 2017 | Series A | $38M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
